Flexion Therapeutics, Inc. has filed an IPO in the amount of $86.25 million. Flexion intend to use the net proceeds from this offering for development expenses, acquire or invest in complementary businesses, working capital and other general corporate purposes.
Flexion Therapeutics, Inc.
Equities
FLXN
US33938J1060
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+20.03% | 126B | |
+23.61% | 117B | |
+22.85% | 27.52B | |
-18.07% | 20.87B | |
-14.39% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |